TABLE 3.

Clinical signs, symptoms, and virological features of 79 pediatric patients with an EV-induced respiratory infection diagnosed during the study period (1999 to 2005)

Signs and symptomsTotal no. of patients (%)Mean age in yr (SD)No. of males/no. of femalesMultiple infectionClinical outcome (fatal/good)EV VP1 genotyping (no of strains)a
Bronchiolitis34 (43)0.7 (0.7)21/13 Streptococcus pneumoniae 0/34Cox B2 (5), Cox B4 (2), Cox B5 (1), cox A16 (3), Echo 3 (2), Echo 6 (5), Echo 7 (4), Echo 11 (3), Echo 13 (3), Echo 18 (1), Echo 30 (5)
Flu-like illness17 (21)2.1 (2.6)10/7 Moraxella catarrhalis 1/16Cox B2 (2), Cox B4 (2), Cox A9 (1), Ent 71 (1), Echo 3 (1), Echo 6 (2), Echo 11 (5), Echo 13 (1), Echo 30 (2)
Sore throat9 (11)5.8 (3.7)7/20/9Echo 5 (1), Echo 7 (1), Echo 6 (1), Echo 11 (4), Echo 13 (1), Echo 30 (1)
Asthma attack6 (8)3.6 (2.0)6/00/6Cox B2 (1), Cox A16 (1), Echo 6 (1), Echo 11 (1), Echo 13 (2)
Rhinopharyngitis4 (5)5.3 (5.4)3/10/4Cox B2 (1), Echo 6 (1), Echo 11 (2)
Pharyngitis3 (4)8.8 (4.2)2/10/3Echo 13 (2), Echo 30 (1)
Bronchitis3 (4)0.7 (0.5)2/1 Haemophilus influenzae 0/3Echo 7 (1), Echo 11 (2)
Rhinitis3 (4)1.3 (1.2)1/20/3Cox B5 (1), Echo 11 (2)
Total79 (100)2.4 (3.1)52/271/78
  • a Cox, coxsackievirus; Echo, echovirus.